Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

801

1

GSR III Acquisition Corp. GSR III Acquisition Corp. Reports Financial Performance for Fiscal Year Ending December 31, 2024

Via official filing (AI summary) | 24 days ago | 0 comments

802

1

BIO-PATH HOLDINGS INC Bio-Path Holdings Reports $9.9 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

803

1

VirTra, Inc VirTra Reports 32% Revenue Decline to $26.4 Million for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

804

1

RELMADA THERAPEUTICS, INC. Relmada Therapeutics Reports Decreased Net Loss and Strategic Shift in Drug Development

Via official filing (AI summary) | 24 days ago | 0 comments

805

1

Neuronetics, Inc. Neuronetics Reports 5% Revenue Increase to $74.9 Million, Faces $43.7 Million Net Loss

Via official filing (AI summary) | 24 days ago | 0 comments

806

1

Acumen Pharmaceuticals, Inc. Acumen Pharmaceuticals Reports $102.3 Million Net Loss for 2024, Driven by Increased R&D Expenses

Via official filing (AI summary) | 24 days ago | 0 comments

807

1

Tempest Therapeutics, Inc. Tempest Therapeutics Reports $41.8 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

808

1

Linkhome Holdings Inc. Linkhome Holdings Inc. Reports 456% Revenue Growth to $7.62 Million in 2024

Via official filing (AI summary) | 24 days ago | 0 comments

809

1

Clearside Biomedical, Inc. Clearside Biomedical Reports $34.4 Million Net Loss and Decreased Revenue for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

810

1

ZION OIL & GAS INC Zion Oil & Gas Reports $7.34 Million Net Loss for Fiscal Year 2024, Receives New Exploration License

Via official filing (AI summary) | 24 days ago | 0 comments

811

1

Pony Group Inc. Pony Group Inc. Reports 45% Revenue Decline and Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

812

1

SK Growth Opportunities Corp SK Growth Opportunities Corp. Reports $3.2M Net Income for 2024, Signs Business Combination Agreement with Webull

Via official filing (AI summary) | 24 days ago | 0 comments

813

1

Spero Therapeutics, Inc. Spero Therapeutics Reports $68.6 Million Net Loss for 2024, Decreased Collaboration Revenue

Via official filing (AI summary) | 24 days ago | 0 comments

814

1

FACT II Acquisition Corp. FACT II Acquisition Corp. Reports No Revenue and $71,891 Net Loss for Fiscal Year Ending December 31, 2024

Via official filing (AI summary) | 24 days ago | 0 comments

815

1

Texas Community Bancshares, Inc. Texas Community Bancshares Reports $1.3 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

816

1

Tyra Biosciences, Inc. Tyra Biosciences Reports $86.48 Million Net Loss for 2024, Increases R&D Spending

Via official filing (AI summary) | 24 days ago | 0 comments

817

1

Gain Therapeutics, Inc. Gain Therapeutics Reports $20.4 Million Net Loss for Fiscal Year 2024, No Revenue Generated

Via official filing (AI summary) | 24 days ago | 0 comments

818

1

IRIDEX CORP IRIDEX Corporation Reports $48.7 Million Revenue and $8.9 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

819

1

NEXTNRG, INC. NextNRG Reports $16.2 Million Net Loss Despite 19.6% Revenue Growth in 2024

Via official filing (AI summary) | 24 days ago | 0 comments

820

1

Kodiak Sciences Inc. Kodiak Sciences Reports $176.2 Million Net Loss for 2024, Decreased R&D Expenses

Via official filing (AI summary) | 24 days ago | 0 comments

821

1

Inhibikase Therapeutics, Inc. Inhibikase Therapeutics Reports $27.5 Million Net Loss for 2024, Increases R&D Spending

Via official filing (AI summary) | 24 days ago | 0 comments

822

1

FOOT LOCKER, INC. Foot Locker Reports Decline in Sales but Recovery in Net Income for Fiscal Year Ending February 2025

Via official filing (AI summary) | 24 days ago | 0 comments

823

1

FB Bancorp, Inc. /MD/ FB Bancorp Reports $6.2 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

824

1

NEXGEL, INC. NexGel Reports 112.5% Revenue Growth to $8.7 Million in 2024

Via official filing (AI summary) | 24 days ago | 0 comments

825

1

Precipio, Inc. Precipio Reports $4.3 Million Net Loss and 22% Revenue Growth for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments